Identifying prevalence and risk factors for metformin non-persistence: a retrospective cohort study using an electronic health record

OBJECTIVES: Non-persistence may be a significant barrier to the use of metformin. Our objective was to assess reasons for metformin non-persistence, and whether initial metformin dosing or use of extended release (ER) formulations affect persistence to metformin therapy. DESIGN: Retrospective cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Flory, James H, Keating, Scott Justin, Siscovick, David, Mushlin, Alvin I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059278/
https://www.ncbi.nlm.nih.gov/pubmed/30037872
http://dx.doi.org/10.1136/bmjopen-2018-021505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059278/
https://www.ncbi.nlm.nih.gov/pubmed/30037872
http://dx.doi.org/10.1136/bmjopen-2018-021505

Ejemplares similares